Eprodisate: Development discontinued

Bellus discontinued its NC-503 diabetes development program after the compound

Read the full 104 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE